课题基金 / 基金详情

Validation of blocking TSP4/Cava2d1 interaction as a new target for neuropathic pain

Validation of blocking TSP4/Cava2d1 interaction as a new target for neuropathic pain
验证阻断 TSP4/Cava2d1 相互作用作为神经性疼痛的新靶点
批准号:
10552492
负责人:
ZHIGANG David LUO
金额:
$9.59万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-05-01 至 2024-04-30

项目摘要

项目成果

ZHIGANG David LUO的其他基金

相似基金

相关文献

中文摘要
翻译
摘要 我们从当前的HEAL-Initiative奖项(1 R 01 DE 029202)中生成各种数据集和文件类型。 由于这些单独的数据集中的许多数据集可能尚未接受用于传输到 存储在选定的存储库中,数据集中管理和共享非常困难,如果不是不可能的话 其他人的访问,交叉兼容性,解释,重用和长期保存。改善我们的数据 管理和共享的做法,我们建议如下:(1)进行自我评估的计划, 根据公平评估的指导方针,确定我们数据中唯一的公平性差距或缺陷 服务(FAIRSharing.org);(2)改善数据公平性和开发或增强数据的计划 管理和共享计划符合当前NIH政策;(3)实施增强的步骤 数据管理和共享。成功完成提案将提高我们的数据公平性,数据 管理和共享实践,以确保符合NIH数据管理和共享政策。
英文摘要
Abstract We generate a wide variety of datasets and file types from our current HEAL-Initiative award (1R01DE029202). Since a lot of these individual datasets may not have accepted community standards for transmission to and storage at selected repositories, it is very difficult, if not impossible, for data centralized management and sharing access by others, cross-discoverability, interpretation, reuse, and long-term preservation. To improve our data management and sharing practice, we propose the following: (1) plans for conducting a self-assessment to identify gaps or deficiencies in FAIRness unique to our data based on the guidelines from FAIR Evaluation Services (FAIRSharing.org); (2) Plans for improving data FAIRness and developing or enhancing a data management and sharing plan to be in line with current NIH policies; (3) Steps toward implementing enhanced data management and sharing. Successful completion of the proposal will improve our data FAIRness, data management and sharing practice to ensure in line with the NIH Policy for Data Management and Sharing.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Validation of blocking TSP4/Cava2d1 interaction as a new target for neuropathic pain
  • 批准号:
    10452913
  • 项目类别:
  • 资助金额:
    $7.99万
  • 财政年份:
    2021
  • 负责人:
    ZHIGANG David LUO
  • 依托单位:
Validation of blocking TSP4/Cava2d1 interaction as a new target for neuropathic pain
  • 批准号:
    10670457
  • 项目类别:
  • 资助金额:
    $9.66万
  • 财政年份:
    2019
  • 负责人:
    ZHIGANG David LUO
  • 依托单位:
Nanoparticle mediated in vivo cell-type specific drug delivery for pain relief
  • 批准号:
    8364809
  • 项目类别:
  • 资助金额:
    $22.18万
  • 财政年份:
    2012
  • 负责人:
    ZHIGANG David LUO
  • 依托单位:
Nanoparticle mediated in vivo cell-type specific drug delivery for pain relief
  • 批准号:
    8501694
  • 项目类别:
  • 资助金额:
    $17.39万
  • 财政年份:
    2012
  • 负责人:
    ZHIGANG David LUO
  • 依托单位:
海外基金